Conditions · Pancreatic cancer
Pancreatic cancer — Phase 2 trials
Prefer to look first? Browse the live map without signing up.
28 open options
- TRIALPHASE1 / PHASE2NOT_YET_RECRUITING
GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Locally Advanced or Metastatic PDAC
SHR-1701 · Apatinib · gemcitabine — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
AGEN2373 · Balstilimab · Cyclophosphamide — 1 site
- TRIALPHASE1 / PHASE2NOT_YET_RECRUITING
Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer
Samuraciclib + Gemcitabine & Nab-Paclitaxel — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
JAB-23E73 · JAB-23E73 — 32 sites
- TRIALPHASE1 / PHASE2RECRUITING
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
EGFR FPBMC — 1 site
- TRIALPHASE2RECRUITING
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Zanidatamab — 28 sites
- TRIALPHASE2RECRUITING
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
Bupivacaine · Hydromorphone · Iopamidol — 1 site
- TRIALPHASE2RECRUITING
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Riluzole · Placebo — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VMD-928 100 mg Tablet · VMD-928 Tablet and Pembrolizumab (200 mg) — 15 sites
- TRIALPHASE2RECRUITING
Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases
pH-NASOX-Immune Group — 1 site
- TRIALPHASE2RECRUITING
NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial
Biospecimen Collection · Computed Tomography · Fluorouracil — 1 site
- TRIALPHASE2NOT_YET_RECRUITING
A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer
BLEX 404
- TRIALPHASE2RECRUITING
Using Tumor Models to Determine Treatments
Cobimetinib · Ponatinib · Brigatinib — 1 site
- TRIALPHASE2RECRUITING
Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Cemiplimab Plus Gemcitabine — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
EBNK-001 + IL-15 + Pembrolizumab — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA — 1 site
- TRIALPHASE2RECRUITING
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Belzutifan — 84 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
CT3001 · FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) — 1 site
- TRIALPHASE1 / PHASE2NOT_YET_RECRUITING
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer
Oncolytic virus VRT106 · Chemotherapy — 1 site
- TRIALPHASE2NOT_YET_RECRUITING
Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
irinotecan liposome + oxaliplatin + 5-FU / LV · Adebellizumab
- TRIALPHASE2RECRUITING
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
IBI343,Gemcitabine, Albumin-bound Paclitaxel — 1 site
- TRIALPHASE1 / PHASE2RECRUITING
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
BMS-986523 · Gemcitabine · Nab-Paclitaxel — 8 sites
- TRIALPHASE2RECRUITING
A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
Pimicotinib (ABSK021) — 5 sites
- TRIALPHASE1 / PHASE2RECRUITING
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
XNW28012 — 24 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A2B694 · A2B543 · xT CDx with HLA-LOH Assay — 12 sites
- TRIALPHASE1 / PHASE2NOT_YET_RECRUITING
PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)
Radiotherapy · Immunotherapy:Granulocyte macrophage-colony stimulating factor(GM-CSF)、Cadumilimab · Chemotherapy:Albumin-bound paclitaxel、Gemcitabine
- TRIALPHASE2RECRUITING
BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
[68Ga]Ga-FAPI-46 — 1 site
- TRIALPHASE2RECRUITING
HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
HRS-4642+AG +Adebrelimab — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.